The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function ; volume:13 ; number:1 ; day:21 ; month:6 ; year:2023 ; pages:1-12 ; date:12.2023
Scientific reports ; 13, Heft 1 (21.6.2023), 1-12, 12.2023
- Creator
-
Balasko, Allison L.
Kowatsch, Monika M.
Graydon, Colin
Lajoie, Julie
Fowke, Keith R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-36468-8
- URN
-
urn:nbn:de:101:1-2023092210155292415528
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Balasko, Allison L.
- Kowatsch, Monika M.
- Graydon, Colin
- Lajoie, Julie
- Fowke, Keith R.
- SpringerLink (Online service)
Other Objects (12)
PD‐1 blocking antibodies moonlighting as killers
Novel immune checkpoints beyond PD-1 in advanced melanoma
Defining innate immune checkpoints controlling Natural Killer cell recognition of melanoma cells
Invariant natural killer T cells in lung diseases
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Grundlagen: Signalwege und Checkpoints
Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
Comparative Analysis of Inhibitory and Activating Immune Checkpoints PD-1, PD-L1, CD28, and CD86 in Non-Melanoma Skin Cancer
PD‐1 blocking antibodies moonlighting as killers
Novel immune checkpoints beyond PD-1 in advanced melanoma
Defining innate immune checkpoints controlling Natural Killer cell recognition of melanoma cells
Invariant natural killer T cells in lung diseases
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Grundlagen: Signalwege und Checkpoints
Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
Comparative Analysis of Inhibitory and Activating Immune Checkpoints PD-1, PD-L1, CD28, and CD86 in Non-Melanoma Skin Cancer
PD‐1 blocking antibodies moonlighting as killers
Novel immune checkpoints beyond PD-1 in advanced melanoma
Defining innate immune checkpoints controlling Natural Killer cell recognition of melanoma cells
Invariant natural killer T cells in lung diseases
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Grundlagen: Signalwege und Checkpoints
Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases